Skip to main content
. 2018 Oct 3;8(10):93. doi: 10.1038/s41408-018-0131-2

Table 1.

The CLL-International Prognostic Index30

Prognostic factor Points
Del17p on FISH or TP53 mutation 4
Unmutated IGHV genes 2
Serum β2 microglobulin >3.5 mg/L 2
Rai stage I–IV 1
Age >65 years 1
Cumulative CLL-IPI score Risk category 5-year TFSa
0–1 Low risk 78%
2–3 Intermediate risk 54%
4–6 High risk 32%
7–10 Very high risk 0%

FISH fluorescence in situ hybridization, IGHV immunoglobulin heavy chain gene, TFS treatment-free survival

aFor the Mayo validation cohort